CNBC Television

Robinhood CEO Vlad Tenev joins CNBC's "Squawk Box" to discuss the future of agentic trading.

Watch more of the interview in related video.

2 0

Shares of Moderna and Merck are surging on positive results from a Phase 3 trial of a groundbreaking cancer treatment. After a decade in development, individualized mRNA “vaccines” and established cancer treatment Keytruda result in reduced risk of recurrence or death. Moderna CEO Stephane Bancel and Merck Research Laboratories president Dr. Dean Li discuss this pivotal moment in medicine and how it fits into the long term visions for both Merck and Moderna. CEO of design and coding platform Figma Dylan Field discusses his company’s wild year as a public company and building public trust in AI. Plus, it was primary night for Democrats in Florida, investors are scrutinizing revenues from Anthropic and OpenAI, and shares of Unitree are surging in Shanghai, presenting a potential challenge to U.S.-based humanoid robotics.

In this episode:
Dylan Field, @zoink
Becky Quick, @BeckyQuick
Andrew Ross Sorkin, @andrewrsorkin
Katie Kramer, @Kramer_Katie

For access to live and exclusive video from CNBC subscribe to CNBC PRO: https://cnb.cx/42d859g

» Subscribe to CNBC TV: https://cnb.cx/SubscribeCNBCtelevision
» Subscribe to CNBC: https://cnb.cx/SubscribeCNBC
» Watch CNBC on the go with CNBC+: https://www.cnbc.com/WatchCNBCPlus


Turn to CNBC TV for the latest stock market news and analysis. From market futures to live price updates CNBC is the leader in business news worldwide.

Connect with CNBC News Online
Get the latest news: http://www.cnbc.com/
Follow CNBC on LinkedIn: https://cnb.cx/LinkedInCNBC
Follow CNBC News on Instagram: https://cnb.cx/InstagramCNBC
Follow CNBC News on Facebook: https://cnb.cx/LikeCNBC
Follow CNBC on Threads: https://cnb.cx/threads
Follow CNBC News on X: https://cnb.cx/FollowCNBC
Follow CNBC on WhatsApp: https://cnb.cx/WhatsAppCNBC

https://www.cnbc.com/select/best-credit-cards/

#CNBC
#CNBCTV

1 0

Unitree’s blockbuster IPO has put China’s humanoid robotics industry in the spotlight.

But as investors pile in, the company faces a bigger test: proving it can scale commercially while navigating growing U.S. restrictions.

CNBC’s Elaine Yu reports.

3 0

Marc Segura, the President of ABB Robotics, tells CNBC’s Ritika Gupta that industrial robotics is entering a new era as machine and artificial intelligence converge. He also discusses China’s Unitree IPO, Europe’s role in the global robotics and physical AI race, and SoftBank’s impending acquisition of ABB Robotics, which he says is on track for year-end.

2 0

CNBC Business News Update with Jessica Ettinger - Markets & Business News With Expert Analysis From Top Business Names. Visit CNBC.com For More.

For access to live and exclusive video from CNBC subscribe to CNBC PRO: https://cnb.cx/42d859g

» Subscribe to CNBC TV: https://cnb.cx/SubscribeCNBCtelevision
» Subscribe to CNBC: https://cnb.cx/SubscribeCNBC
» Watch CNBC on the go with CNBC+: https://www.cnbc.com/WatchCNBCPlus


Turn to CNBC TV for the latest stock market news and analysis. From market futures to live price updates CNBC is the leader in business news worldwide.

Connect with CNBC News Online
Get the latest news: http://www.cnbc.com/
Follow CNBC on LinkedIn: https://cnb.cx/LinkedInCNBC
Follow CNBC News on Instagram: https://cnb.cx/InstagramCNBC
Follow CNBC News on Facebook: https://cnb.cx/LikeCNBC
Follow CNBC on Threads: https://cnb.cx/threads
Follow CNBC News on X: https://cnb.cx/FollowCNBC
Follow CNBC on WhatsApp: https://cnb.cx/WhatsAppCNBC

https://www.cnbc.com/select/best-credit-cards/

#CNBC
#CNBCTV

5 31

CNBC's Eunice Yoon joins 'Squawk on the Street' to discuss Unitree Robotics shares closing over 460% higher Wednesday as the Chinese humanoid robot maker made its stock market debut in Shanghai.

29 16

Unitree Robotics’ shares rose 542% on Wednesday in its Shanghai market debut.

The Chinese robotics maker raised about 6.1 billion yuan ($905 million) in its IPO.

14 0

CNBC’s Robert Frank joins "Squawk Box" with the latest on the California billionaire tax debate.

15 1

Moderna CEO Stephane Bancel & Merck Research Laboratories President Dr. Dean Li join CNBC's "Squawk Box" to discuss Keytruda, an experimental personalized cancer vaccine that showed positive initial results in its first-ever late-stage trial.

Watch more in related video.

13 1

Michael Duffey, Under Secretary of War for Acquisition and Sustainment, discusses U.S. munitions readiness and multiyear deals to expand missile production and defense capacity.

6 0

An experimental personalized cancer vaccine from Merck and Moderna showed positive initial results in its first-ever late-stage trial.

The combination regimen met the main study goal of significantly extending the time patients lived without their melanoma returning, compared with Keytruda alone, and also reduced the risk of the cancer spreading to distant parts of the body.

8 1

President Donald Trump delivers remarks with technology leaders at the White House on Wednesday.

For access to live and exclusive video from CNBC subscribe to CNBC PRO: https://cnb.cx/42d859g

» Subscribe to CNBC TV: https://cnb.cx/SubscribeCNBCtelevision
» Subscribe to CNBC: https://cnb.cx/SubscribeCNBC
» Watch CNBC on the go with CNBC+: https://www.cnbc.com/WatchCNBCPlus

Turn to CNBC TV for the latest stock market news and analysis. From market futures to live price updates CNBC is the leader in business news worldwide.

Connect with CNBC News Online
Get the latest news: http://www.cnbc.com/
Follow CNBC on LinkedIn: https://cnb.cx/LinkedInCNBC
Follow CNBC News on Instagram: https://cnb.cx/InstagramCNBC
Follow CNBC News on Facebook: https://cnb.cx/LikeCNBC
Follow CNBC on Threads: https://cnb.cx/threads
Follow CNBC News on X: https://cnb.cx/FollowCNBC
Follow CNBC on WhatsApp: https://cnb.cx/WhatsAppCNBC

https://www.cnbc.com/select/best-credit-cards/

#CNBC
#CNBCTV

LIVE: President Trump delivers remarks with technology leaders — 8/19/2026

7 0